These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 3039058)

  • 21. Binding of (+)-PN 200-110 to rat pituitaries and to normal and adenomatous human pituitaries.
    Bression D; Chaumet-Riffaud P; Brandi AM; Comte A; Peillon F; Kiechel JR
    Mol Cell Endocrinol; 1987 Apr; 50(3):255-61. PubMed ID: 3032711
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Selective modulation by membrane potential of the interaction of some calcium entry blockers with calcium channels in rat mesenteric artery.
    Morel N; Godfraind T
    Br J Pharmacol; 1988 Sep; 95(1):252-8. PubMed ID: 2851351
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Regulation of 1,4-dihydropyridine and beta-adrenergic receptor sites in coronary artery smooth muscle membranes.
    Drimal J
    Cell Signal; 1991; 3(3):225-32. PubMed ID: 1716451
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Voltage-dependent binding of 1,4-dihydropyridine Ca2+ channel antagonists and activators in cultured neonatal rat ventricular myocytes.
    Wei XY; Rutledge A; Triggle DJ
    Mol Pharmacol; 1989 Apr; 35(4):541-52. PubMed ID: 2539561
    [TBL] [Abstract][Full Text] [Related]  

  • 25. (+)-[3H]-PN 200-110 binding to cell membranes and intact strips of portal vein smooth muscle: characterization and modulation by membrane potential and divalent cations.
    Dacquet C; Loirand G; Rakotoarisoa L; Mironneau C; Mironneau J
    Br J Pharmacol; 1989 May; 97(1):256-62. PubMed ID: 2524235
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Calcium antagonist binding sites in failing and nonfailing human ventricular myocardium.
    Rasmussen RP; Minobe W; Bristow MR
    Biochem Pharmacol; 1990 Feb; 39(4):691-6. PubMed ID: 2154992
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Depolarization of chick myotubes triggers the appearance of (+)-[3H]PN 200-110-binding sites.
    Pauwels PJ; Van Assouw HP; Leysen JE
    Mol Pharmacol; 1987 Dec; 32(6):785-91. PubMed ID: 2826992
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Dihydropyridine binding sites in aerobically perfused, ischemic, and reperfused rat hearts: effect of temperature and time.
    Gu XH; Dillon JS; Nayler WG
    J Cardiovasc Pharmacol; 1988 Sep; 12(3):272-8. PubMed ID: 2464098
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Binding sites for 1,4-dihydropyridine Ca(2+)-channel modulators in rat intestinal smooth muscle.
    Salomone S; Wibo M; Morel N; Godfraind T
    Naunyn Schmiedebergs Arch Pharmacol; 1991 Dec; 344(6):698-705. PubMed ID: 1837846
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Biochemical characterization of ethanol actions on dihydropyridine-sensitive calcium channels in brain synaptosomes.
    Canda A; Yu BH; Sze PY
    Biochem Pharmacol; 1995 Nov; 50(10):1711-8. PubMed ID: 7503775
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Dihydropyridine-sensitive Ca2+ channels: molecular properties of interaction with Ca2+ channel blockers, purification, subunit structure, and differentiation.
    Lazdunski M; Barhanin J; Borsotto M; Fosset M; Galizzi JP; Renaud JF; Romey G; Schmid A
    J Cardiovasc Pharmacol; 1986; 8 Suppl 8():S13-9. PubMed ID: 2433514
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Characterization of 1,4, dihydropyridine calcium channel binding sites in the human prostate.
    Rosenthal E; Shapiro E; Lepor H
    J Urol; 1990 Dec; 144(6):1539-42. PubMed ID: 1700163
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Characterization in rat aorta of the binding sites responsible for blockade of noradrenaline-evoked calcium entry by nisoldipine.
    Morel N; Godfraind T
    Br J Pharmacol; 1991 Feb; 102(2):467-77. PubMed ID: 1826619
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Dihydropyridine receptor binding sites in the cardiomyopathic hamster heart are unchanged from control.
    Bazan E; Sole MJ; Schwartz A; Johnson CL
    J Mol Cell Cardiol; 1991 Feb; 23(2):111-7. PubMed ID: 1648625
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Identification of a novel calcium antagonist binding site in rat brain by SR 33557.
    Kenny BA; Fraser S; Spedding M
    Br J Pharmacol; 1993 Jan; 108(1):93-9. PubMed ID: 7679034
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Control of expression of the 1,4-dihydropyridine receptor in BC3H1 cells.
    Rampe D; Caffrey JM; Schneider MD; Brown AM
    Biochem Biophys Res Commun; 1988 Apr; 152(2):769-75. PubMed ID: 2835042
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Influence of Mg++ on the effect of diltiazem to increase dihydropyridine binding to receptors on Ca++-channels in chick cardiac and skeletal muscle membranes.
    Maan AC; Ptasienski J; Hosey MM
    J Pharmacol Exp Ther; 1986 Dec; 239(3):768-74. PubMed ID: 2432217
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Kinetics of binding of dihydropyridine calcium channel ligands to skeletal muscle membranes: evidence for low-affinity sites and for the involvement of G proteins.
    Dunn SM; Bladen C
    Biochemistry; 1991 Jun; 30(23):5716-21. PubMed ID: 1645998
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Binding Ca2+ to intracellular or to extracellular sites of dihydropyridine receptor of rabbit skeletal muscle discriminates between in vitro binding of Ca2+-channel agonist and antagonist.
    Kanngiesser U; Pongs O
    Eur J Biochem; 1989 May; 181(2):467-73. PubMed ID: 2540975
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Increase in [3H]PN 200-110 binding to cardiac muscle membrane in streptozocin-induced diabetic rats.
    Nishio Y; Kashiwagi A; Ogawa T; Asahina T; Ikebuchi M; Kodama M; Shigeta Y
    Diabetes; 1990 Sep; 39(9):1064-9. PubMed ID: 2143487
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.